Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Anterior Choroidal Artery Infarction

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Anterior Choroidal Artery Infarction in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pérez-Asensio, FJ1
Hurtado, O1
Burguete, MC1
Moro, MA1
Salom, JB1
Lizasoain, I1
Torregrosa, G1
Leza, JC1
Alborch, E1
Castillo, J1
Knowles, RG1
Lorenzo, P1
Parmentier, S1
Böhme, GA1
Lerouet, D1
Damour, D1
Stutzmann, JM1
Margaill, I1
Plotkine, M1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Anterior Choroidal Artery Infarction

ArticleYear
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
    Neurobiology of disease, 2005, Volume: 18, Issue:2

    Topics: Adenosine Triphosphate; Amidines; Amino Acid Transport System X-AG; Animals; Benzylamines; Brain; Ce

2005
Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury.
    British journal of pharmacology, 1999, Volume: 127, Issue:2

    Topics: Amidines; Animals; Benzylamines; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; E

1999